Skip to main navigation
Skip to main content
Skip to Footer
Google Tag Manager
US
Novartis site directory
Our Products
US Products By Brand
Product Portfolio
Our Process
Therapeutic Areas
Patient Assistance
Product Related Issues
About Us
Who We Are
Diversity and Inclusion
Our Leadership
Supplier Diversity
Research
Contact Us
Corporate Responsibility
Novartis in Society US Reports
Corporate Citizenship
Business Conduct
Corporate Integrity Agreement
Payments to Healthcare Professionals
Payments to Healthcare Organizations
Physician Payments - Sunshine Act
Post-Marketing Commitments
Enhanced Verification Request
News
News Archive
Statements
Stories
US Media Contacts
Novartis US COVID-19 Initiatives
Careers
Careers Search
Working at Novartis
Employee Benefits
Awards & Recognition
NIBR Careers Frequently Asked Questions
Search
News Archive
Advanced Search
Basic Search
From Date:
To Date:
Show:
All
Media Releases
Stories
Filter By
2019
December
Media Release
/
Dec 09, 2019
Novartis Kymriah® demonstrates consistent efficacy and safety outcomes in US patients when used in real-world setting
Read More
November
Media Release
/
Nov 17, 2019
Novartis PARAGON-HF analyses suggest Entresto® benefit beyond HFrEF
Read More
Media Release
/
Nov 15, 2019
New Novartis medicine Adakveo® (crizanlizumab-tmca) approved by FDA to reduce frequency of pain crises in individuals living with sickle cell disease
Read More
Media Release
/
Nov 13, 2019
Novartis launches PsO at Work with music icon Cyndi Lauper to bring to life the impact psoriasis can have in the workplace
Read More
Media Release
/
Nov 11, 2019
New Novartis data to be presented at American Heart Association SS2019 suggest broader clinical benefit of Entresto in chronic heart failure
Read More
Media Release
/
Nov 08, 2019
Novartis receives FDA approval for BEOVU®, offering wet AMD patients vision gains and greater fluid reductions vs aflibercept
Read More
October
Media Release
/
Oct 08, 2019
Novartis STEP Program™ now accepting submissions for proposals that address unmet patient needs in cancer biomarker testing
Read More
Media Release
/
Oct 08, 2019
Novartis receives FDA approval for BEOVU®, offering wet AMD patients vision gains and greater fluid reductions vs aflibercept
Read More
Media Release
/
Oct 02, 2019
Novartis positive 52-week PREVENT data confirm Cosentyx® efficacy in addressing entire axSpA spectrum
Read More
Media Release
/
Oct 01, 2019
Novartis Entresto receives FDA approval for pediatric heart failure, helping to address critical unmet need for treatment options
Read More
Search Results Navigation
First page
« first
Previous page
‹ previous
…
Page
3
of 5
Page
4
of 5
Current page
5
of 5
Page
6
of 5
Page
7
of 5
…
Next page
next ›
Last page
last »
Share
Email
Jump to Comments
Print
Save
Related Links
Novartis joins the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) initiative
You are here
Home
›
News
